US equities |
NVDA $237.07 ▲+1.33% SPCX $165.41 ▲+4.06% MU $1,059.01 ▼-1.48% TSLA $376.24 ▲+1.52% MSFT $527.25 ▲+1.88% INTC $116.13 ▼-2.68% SNDK $1,716.65 ▼-0.19% AMD $627.66 ▼-0.99%
FinancialContent

Glaukos Corporation Common Stock (NY:GKOS)

164.19 +0.44 (+0.27%)
Delayed Quote Updated: 10:02 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Glaukos Corp (NYSE:GKOS) Reports Record 2025 Sales but Shares Dip on Wider Loss, Conservative Outlook ↗
Via Chartmill
News headline image
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
From Glaukos Corporation
Via Business Wire
News headline image
Director Sells GKOS 15,000 Shares for $1.9 Million ↗
This ophthalmic device maker, focused on glaucoma solutions, reported a notable insider sale after a challenging year for its stock. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
From Glaukos Corporation
Via Business Wire
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
From Glaukos Corporation
Via Business Wire
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
From Glaukos Corporation
Via Business Wire
News headline image
Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off ↗
Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos Announces Participation in Upcoming Investor Conferences
From Glaukos Corporation
Via Business Wire
News headline image
Why Glaukos Stock Zoomed Almost 14% Higher on Thursday ↗
The company's recent past featured robust growth, and it anticipates continued rises into the near future. 
Via The Motley Fool
News headline image
Glaukos (GKOS) Q3 2025 Earnings Call Transcript ↗
Glaukos (GKOS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why Glaukos Stock Jumped Over 20% After-Hours Today ↗
Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance. 
Via Stocktwits
News headline image
What's going on in today's after hours session ↗
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
Glaukos Corp (NYSE:GKOS) Soars on Strong Q3 2025 Earnings Beat and Robust 2026 Outlook ↗
Glaukos (GKOS) smashed Q3 2025 earnings forecasts, sending its stock soaring. The company posted record revenue and raised its 2025 and 2026 sales guidance. 
Via Chartmill
Topics Earnings
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Glaukos Announces Third Quarter 2025 Financial Results
From Glaukos Corporation
Via Business Wire
News headline image
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
 
Via Benzinga
News headline image
Glaukos Announces FDA Approval of Epioxa™
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
From Glaukos Corporation
Via Business Wire
News headline image
Expert Outlook: Glaukos Through The Eyes Of 7 Analysts ↗
 
Via Benzinga
News headline image
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
From Glaukos Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >